Validating a Human Cell Model of Null Galactosylceramidase ( GALC ) Enzyme Activity That Recapitulates Krabbe Disease
Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)
DOI: 10.1002/jimd.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 10.06.2026. Verfasst von Rodrigo T Starosta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Galactosylceramidase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Washington University in St. Louis, NIH HHS.
Abstract (Originalsprache)
Krabbe Disease (KD) is a lysosomal leukodystrophy characterized by the production of psychosine in oligodendrocytes, leading to neurodegeneration and ultimately death. The only treatment modality currently available for this disease is hematopoietic stem cell transplantation (HSCT), a procedure with high morbidity, highlighting the need for further therapies to be developed. In this study, we established and characterized GALC knockout MO3.13 cells, a cell line derived from human oligodendrocytes, as a model for KD. Clonal MO3.13 cells with GALC KO were obtained via CRISPR/Cas9‐mediated gene editing. GALC activity was measured by a 4‐methylumbellyferyl (4‐MU)‐based assay, and morphology analyses were performed using light microscopy and transmission electron microscopy. Psychosine was measured by liquid chromatography–tandem mass spectrometry (LC–MS/MS). The GALC KO cells have elevated levels of psychosine and an increased number of autophagosomes, autolysosomes, and cytoplasmic granules on transmission electron microscopy. Glycogen abundance was decreased in GALC KO cells compared to controls. After administration of BMN‐S202, a ceramide galactosyltransferase inhibitor, psychosine levels in GALC KO cells were reduced back to WT levels. In conclusion, we demonstrated that the GALC KO MO3.13 cell line recapitulates the KD phenotype and biochemical response to SRT and may be a useful KD model for mechanistic studies and therapeutic development for KD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA.
- Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- McDonnell Genomics Institute, Washington University School of Medicine, St. Louis, Missouri, USA.
- Washington University Center for Cellular Imaging, St. Louis, Missouri, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Förderung
- NINDS NIH HHS
- Washington University in St. Louis
- NIH HHS
- National Institutes of Health
Zitieren
APA
Starosta, R. T., Khatoon, N., Roberts, M. S., Le, S. Q., Austin, G., Cui, X., Strout, G., Schmidt, R. E., Jiang, X., Sands, M. S., & Dickson, P. I. (2026). Validating a Human Cell Model of Null Galactosylceramidase ( GALC ) Enzyme Activity That Recapitulates Krabbe Disease. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70212
Vancouver
Starosta RT, Khatoon N, Roberts MS, Le SQ, Austin G, Cui X, et al. Validating a Human Cell Model of Null Galactosylceramidase ( GALC ) Enzyme Activity That Recapitulates Krabbe Disease. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70212
BibTeX
@article{Starosta2026,
author = {Starosta, Rodrigo T and Khatoon, Nazia and Roberts, Marie S and Le, Steven Q and Austin, Grant and Cui, Xiaoxia and Strout, Gregory and Schmidt, Robert E and Jiang, Xuntian and Sands, Mark S and Dickson, Patricia I},
title = {Validating a Human Cell Model of Null Galactosylceramidase ( GALC ) Enzyme Activity That Recapitulates Krabbe Disease},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {4},
doi = {10.1002/jimd.70212}
}
EUVIMED